StockData
Teladoc Health, Inc. logo

Teladoc Health, Inc. (TDOC) stock

TDOCNYSEServices-Offices & Clinics of Doctors of MedicineFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 4/3043% below fair value
$8.49−0.21 (-2.41%)

Close on Nov 17, 2026Market cap $1.55BP/E –Yield –

Teladoc Health operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Teladoc Health's operating cash flow for the twelve months ending Sep 30, 2026 was $268.38M, down 8.3% year over year. For fiscal 2025 it was $294.36M, up 0.2% from the year before. The highest annual figure on record is $350.02M in fiscal 2023.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025$294.36M+0.2%
FY2024Dec 31, 2024$293.68M-16.1%
FY2023Dec 31, 2023$350.02M+84.9%
FY2022Dec 31, 2022$189.29M-2.4%
FY2021Dec 31, 2021$193.99M–
FY2020Dec 31, 2020-$53.51M-279.2%
FY2019Dec 31, 2019$29.87M–
FY2018Dec 31, 2018-$4.86M–
FY2017Dec 31, 2017-$34.44M–
FY2016Dec 31, 2016-$51.88M–
FY2015Dec 31, 2015-$47.18M–
FY2014Dec 31, 2014-$11.36M–
FY2013Dec 31, 2013-$6.05M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$106.46M+7.2%
Q2 FY2026Jun 30, 2026$64.66M-29.3%
Q1 FY2026Mar 31, 2026$9.52M-40.2%
Q4 FY2025Dec 31, 2025$87.74M+2.1%
Q3 FY2025Sep 30, 2025$99.26M-9.9%
Q2 FY2025Jun 30, 2025$91.43M+3.1%
Q1 FY2025Mar 31, 2025$15.92M+78.5%
Q4 FY2024Dec 31, 2024$85.90M-34.0%
Q3 FY2024Sep 30, 2024$110.18M+4.3%
Q2 FY2024Jun 30, 2024$88.68M-12.4%
Q1 FY2024Mar 31, 2024$8.92M-32.2%
Q4 FY2023Dec 31, 2023$130.08M+98.5%
Q3 FY2023Sep 30, 2023$105.60M+67.6%
Q2 FY2023Jun 30, 2023$101.18M+9.4%
Q1 FY2023Mar 31, 2023$13.16M–
Q4 FY2022Dec 31, 2022$65.55M-21.2%
Q3 FY2022Sep 30, 2022$63.02M-17.7%
Q2 FY2022Jun 30, 2022$92.47M+77.1%
Q1 FY2022Mar 31, 2022-$31.75M–
Q4 FY2021Dec 31, 2021$83.21M–
Q3 FY2021Sep 30, 2021$76.59M+137.9%
Q2 FY2021Jun 30, 2021$52.22M+46.9%
Q1 FY2021Mar 31, 2021-$18.03M–
Q4 FY2020Dec 31, 2020-$114.94M-734.2%
Q3 FY2020Sep 30, 2020$32.20M+138.7%
Q2 FY2020Jun 30, 2020$35.55M+478.1%
Q1 FY2020Mar 31, 2020-$6.32M–
Q4 FY2019Dec 31, 2019$18.12M+631.9%
Q3 FY2019Sep 30, 2019$13.49M+32.5%
Q2 FY2019Jun 30, 2019$6.15M–
Q1 FY2019Mar 31, 2019-$7.89M–
Q4 FY2018Dec 31, 2018$2.48M–
Q3 FY2018Sep 30, 2018$10.18M–
Q2 FY2018Jun 30, 2018-$3.65M–
Q1 FY2018Mar 31, 2018-$13.87M–
Q4 FY2017Dec 31, 2017-$7.28M–
Q3 FY2017Sep 30, 2017-$11.75M–
Q2 FY2017Jun 30, 2017-$2.91M–
Q1 FY2017Mar 31, 2017-$12.51M–
Q4 FY2016Dec 31, 2016-$7.53M–

More Teladoc Health figures

See a number that looks wrong?